Company Filing History:
Years Active: 2015-2016
Title: Ahmed El-Tahtawy: Innovator in Therapeutic Dosage Forms
Introduction
Ahmed El-Tahtawy is a notable inventor based in Brewster, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents, his work focuses on improving the safety and efficacy of therapeutic agents.
Latest Patents
El-Tahtawy's latest patents involve a kit comprising a plurality of dosage forms, including a first dosage form and a second dosage form, each containing a therapeutic agent such as an opioid. The second dosage form has a greater dosage strength than the first. The patents detail that the steady state concentration and the area under the curve (AUC) of both dosage forms are dose proportional. Furthermore, the single dose concentration of the second dosage form is less than the minimum level required for dose proportionality with respect to the first dosage form. These inventions also encompass methods for administering these dosage forms to patients, aiming to enhance safety and patient acceptance.
Career Highlights
Ahmed El-Tahtawy is associated with Purdue Pharma L.P., where he continues to innovate in the pharmaceutical industry. His work is pivotal in developing safer and more effective medication delivery systems.
Collaborations
El-Tahtawy has collaborated with notable colleagues, including Curtis Wright and Robert D. Colucci, contributing to the advancement of therapeutic dosage forms.
Conclusion
Ahmed El-Tahtawy's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving patient care. His work is essential in the ongoing development of effective therapeutic agents.